This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Will American International's (AIG) Q2 Earnings Hit a Pothole?
by Zacks Equity Research
American International's (AIG) second-quarter results are likely to reflect lower profits from General Insurance.
Countdown to American International Group (AIG) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for American International Group (AIG), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
Should iShares Morningstar Mid-Cap Value ETF (IMCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCV
Analysts Estimate American International Group (AIG) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
American International Group (AIG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?
by Zacks Equity Research
Sector ETF report for KBWP
Here's Why Investors Should Hold Corebridge (CRBG) Stock Now
by Zacks Equity Research
Improving premiums, fee and investment income and streamlining initiatives bode well for Corebridge (CRBG).
Why You Should Hold American International (AIG) Stock Now
by Zacks Equity Research
American International (AIG) is expected to benefit from rising premiums in the General Insurance business, improving investment income, enhanced savings from AIG Next, and streamlining initiatives.
Here's Why American International Group (AIG) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
AIG Optimizes Portfolio With Sale of Travel Insurance Business
by Zacks Equity Research
AIG's definitive agreement to sell its global personal travel insurance business to Zurich is expected to free up capital.
Why American International Group (AIG) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does American International Group (AIG) have what it takes? Let's find out.
Zacks Industry Outlook MetLife, American International, Prudential Financial, The Hartford Financial and Old Republic International
by Zacks Equity Research
MetLife, American International, Prudential Financial, The Hartford Financial and Old Republic International have been highlighted in this Industry Outlook article.
5 Multiline Insurers to Watch Amid Rising Insurance Demand
by Tanuka De
Better pricing, product redesigns, technological advancement, high inflation and interest rate rise are expected to aid multiline insurers like MET, AIG, PRU, HIG and ORI.
AIG Reaches Key Milestone With Deconsolidation of Corebridge
by Zacks Equity Research
AIG now owns around 48.35% of Corebridge's common stock.
The Zacks Analyst Blog Highlights Eli Lilly, T-Mobile US, BHP, American International and Exelon
by Zacks Equity Research
Eli Lilly, T-Mobile US, BHP, American International and Exelon are part of the Zacks Analyst Blog.
Top Research Reports for Eli Lilly, T-Mobile & BHP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), T-Mobile US, Inc. (TMUS) and BHP Group Limited (BHP).
AIG to Sell 30M Corebridge Shares Through Secondary Offering
by Zacks Equity Research
AIG revealed the pricing for the secondary offering for CRBG common stock at $29.20 per share.
Why Is American International Group (AIG) Up 0.2% Since Last Earnings Report?
by Zacks Equity Research
American International Group (AIG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should iShares Morningstar Mid-Cap Value ETF (IMCV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IMCV
AIG to Divest 20% Corebridge Stake to Nippon Life for $3.8B
by Zacks Equity Research
AIG continues to streamline its operations to intensify focus on its General Insurance business.
Should You Invest in the Invesco KBW Property & Casualty Insurance ETF (KBWP)?
by Zacks Equity Research
Sector ETF report for KBWP
ProAssurance (PRA) Q1 Earnings Beat on Specialty P&C Unit
by Zacks Equity Research
ProAssurance's (PRA) Q1 results reflect new business growth and strong retention rates, partly offset by higher average claim costs in the Workers' Compensation Insurance segment.
The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes
by Zacks Equity Research
AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.
Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), QUALCOMM Incorporated (QCOM) and FedEx Corporation (FDX).
Company News for May 3, 2024
by Zacks Equity Research
Companies In The News Are: CF, MOS, MGM, AIG.
AIG Beats on Q1 Earnings on Lower Costs, Approves Dividend Hike
by Zacks Equity Research
Higher premiums and deposits in the Life and Retirement unit, and reduced catastrophe losses aid AIG's Q1 results. Management sanctions an increase of up to $10 billion in its buyback authorization.